Daily Archives: March 16, 2023
Anti-BCMA CAR T-Cell therapy clinical trials for relapse/refractory Immune thrombocytopenia(R/R ITP)
March 16th, 2023 UncategorizedMarch 2023: Immune thrombocytopenia (ITP) is a disorder that can lead to easy or excessive bruising and bleeding. Approximately two-thirds of patients achieve remission after/during first-line therapies. However, the other part of patients coul.... Read More
Clinical trial recruitment for BALL CAR T-Cell therapy
March 16th, 2023 Uncategorized16th March 2023: The treatment of cancer is being revolutionized by new immunotherapeutic drugs that target the microenvironment at the tumour site. T cells with chimeric antigen receptors (CAR) are being extensively researched for cancer immun.... Read More
